FOXO4-DRI 10 mg
Description
FOXO4-DRI 10 MG
FOXO4-DRI — Research Grade Peptide
Overview
FOXO4-DRI (FOXO4-derived interfering peptide) is a research-grade peptide supplied for in vitro investigation of senescence pathways, protein–protein interactions, and apoptotic signaling. Supplied as a lyophilized peptide for stability and analytical precision; QC verified for sequence fidelity and batch purity.
Research context
Intended for non-clinical studies, FOXO4-DRI is used to probe FOXO4–p53 interactions, senescent cell biology, apoptosis induction in aged or damaged cells, and mechanistic combination studies with chemotherapeutics or senolytic agents.
Product Information
- Product nameFOXO4-DRI
- SequenceC228H388N86O64
- FormulaPeptide — empirical formula varies by sequence
- Molecular weight~ 5358.06
- CAS number2460055-10-9
- AppearanceWhite to off-white lyophilized powder
- FormLyophilized solid
- Purity>99% (HPLC verified; higher-purity options available on request)
Storage & Handling
- Store at −20 °C; protect from moisture and light.
- Lyophilized for stability; avoid repeated freeze–thaw cycles after reconstitution.
- Follow institutional protocols for reconstitution, aseptic handling, and peptide-specific solvent compatibility.
Research Applications
- Investigation of FOXO4–p53 interaction disruption and downstream apoptotic signaling
- In vitro studies of cellular senescence, senolysis, and age-related cell clearance
- Combination studies with chemotherapeutics, targeted agents, or senolytic compounds
- Mechanistic assays of apoptosis markers, mitochondrial dysfunction, and cell viability
Legal & Safety
For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use. No therapeutic, diagnostic, or dosing claims are made. This product has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease.
